Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation.

Berthelot CC, Kamita SG, Sacchi R, Yang J, Nording ML, Georgi K, Hegedus Karbowski C, German JB, Weiss RH, Hogg RJ, Hammock BD, Zivkovic AM.

PLoS One. 2015 Dec 16;10(12):e0144996. doi: 10.1371/journal.pone.0144996. eCollection 2015.

2.

Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.

Hogg RJ, Bay RC, Jennette JC, Sibley R, Kumar S, Fervenza FC, Appel G, Cattran D, Fischer D, Hurley RM, Cerda J, Carter B, Jung B, Hernandez G, Gipson D, Wyatt RJ.

Am J Kidney Dis. 2015 Nov;66(5):783-91. doi: 10.1053/j.ajkd.2015.06.013. Epub 2015 Jul 21.

PMID:
26209543
3.

Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids.

Nording ML, Yang J, Georgi K, Hegedus Karbowski C, German JB, Weiss RH, Hogg RJ, Trygg J, Hammock BD, Zivkovic AM.

PLoS One. 2013 Oct 24;8(10):e76575. doi: 10.1371/journal.pone.0076575. eCollection 2013.

4.

Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations.

Zivkovic AM, Yang J, Georgi K, Hegedus C, Nording ML, O'Sullivan A, German JB, Hogg RJ, Weiss RH, Bay C, Hammock BD.

Metabolomics. 2012 Dec;8(6):1102-1113.

5.

Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.

Hogg RJ, Friedman A, Greene T, Radeva M, Budisavljevic MN, Gassman J, Gipson DS, Jefferson JA, John EG, Kaskel FJ, Moudgil A, Moxey-Mims M, Ortiz LA, Schelling JR, Schnaper W, Srivastava T, Trachtman H, Vehaskari VM, Wong C, Woronieki RP, Van Why SK, Zolotnitskaya A.

Clin J Am Soc Nephrol. 2013 Feb;8(2):211-8. doi: 10.2215/CJN.08330812. Epub 2012 Nov 8.

6.

Rasburicase for hyperuricemia in hemolytic uremic syndrome.

Acosta AA, Hogg RJ.

Pediatr Nephrol. 2012 Feb;27(2):325-9. doi: 10.1007/s00467-011-2047-y. Epub 2011 Nov 17.

PMID:
22089328
7.

Clinical trial of focal segmental glomerulosclerosis in children and young adults.

Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Hogan SL, Middleton JP, Vehaskari VM, Flynn PA, Powell LM, Vento SM, McMahan JL, Siegel N, D'Agati VD, Friedman AL.

Kidney Int. 2011 Oct;80(8):868-78. doi: 10.1038/ki.2011.195. Epub 2011 Jul 6.

8.

Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.

Gipson DS, Trachtman H, Kaskel FJ, Radeva MK, Gassman J, Greene TH, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Middleton JP, Vehaskari VM, Hogan SL, Vento S, Flynn PA, Powell LM, McMahan JL, Siegel N, Friedman AL.

Kidney Int. 2011 Mar;79(6):678-685. doi: 10.1038/ki.2010.485. Epub 2010 Dec 22.

9.

The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults.

Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, Cook HT, Feehally J, Roberts IS, Amore A, Alpers CE, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator SN, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo AB, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H.

Kidney Int. 2010 May;77(10):921-7. doi: 10.1038/ki.2010.43. Epub 2010 Mar 3.

10.

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.

Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H.

Kidney Int. 2009 Sep;76(5):534-45. doi: 10.1038/ki.2009.243. Epub 2009 Jul 1.

11.

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H.

Kidney Int. 2009 Sep;76(5):546-56. doi: 10.1038/ki.2009.168. Epub 2009 Jul 1.

12.

Idiopathic immunoglobulin A nephropathy in children and adolescents.

Hogg RJ.

Pediatr Nephrol. 2010 May;25(5):823-9. doi: 10.1007/s00467-008-1096-3. Epub 2009 Feb 5. Review.

13.

Screening for CKD in children: a global controversy.

Hogg RJ.

Clin J Am Soc Nephrol. 2009 Feb;4(2):509-15. doi: 10.2215/CJN.01210308. Epub 2008 Dec 31. Review.

14.

Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura.

Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J.

Pediatr Nephrol. 2007 Dec;22(12):2067-72. Epub 2007 Oct 18.

PMID:
17943324
15.

Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.

Hogg RJ, Fitzgibbons L, Bruick J, Bunke M, Ault B, Baqi N, Trachtman H, Swinford R.

Clin J Am Soc Nephrol. 2006 Nov;1(6):1173-8. Epub 2006 Oct 4.

16.

Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent.

Hogg RJ, Fitzgibbons L, Atkins C, Nardelli N, Bay RC; North American IgA Nephropathy Study Group.

Clin J Am Soc Nephrol. 2006 Nov;1(6):1167-72. Epub 2006 Sep 27.

17.

Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group.

Hogg RJ, Lee J, Nardelli N, Julian BA, Cattran D, Waldo B, Wyatt R, Jennette JC, Sibley R, Hyland K, Fitzgibbons L, Hirschman G, Donadio JV Jr, Holub BJ; Southwest Pediatric Nephrology Study Group.

Clin J Am Soc Nephrol. 2006 May;1(3):467-74. Epub 2006 Apr 12.

18.

IgA nephropathy: what's new?

Hogg RJ.

Pediatr Nephrol. 2007 Nov;22(11):1809-14. Epub 2007 Jul 10.

PMID:
17619908
19.

A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension.

Hogg RJ, Delucchi A, Sakihara G, Wells TG, Tenney F, Batisky DL, Blumer JL, Vogt BA, Lo MW, Hand E, Panebianco D, Rippley R, Shaw W, Shahinfar S.

Pediatr Nephrol. 2007 May;22(5):695-701. Epub 2007 Jan 10.

PMID:
17216247
20.

Adolescents with proteinuria and/or the nephrotic syndrome.

Hogg RJ.

Adolesc Med Clin. 2005 Feb;16(1):163-72. Review.

PMID:
15844389
21.

A randomized, placebo-controlled trial of amlodipine in children with hypertension.

Flynn JT, Newburger JW, Daniels SR, Sanders SP, Portman RJ, Hogg RJ, Saul JP; PATH-1 Investigators.

J Pediatr. 2004 Sep;145(3):353-9.

PMID:
15343191
22.

A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616].

Hogg RJ, Wyatt RJ; Scientific Planning Committee of the North American IgA Nephropathy Study.

BMC Nephrol. 2004 Mar 25;5:3.

23.

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation.

Ann Intern Med. 2003 Jul 15;139(2):137-47. Erratum in: Ann Intern Med. 2003 Oct 7;139(7):605.

PMID:
12859163
24.

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.

Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS; National Kidney Foundation's Kidney Disease Outcomes Quality Initiative.

Pediatrics. 2003 Jun;111(6 Pt 1):1416-21.

PMID:
12777562
25.

Long versus standard initial steroid therapy for children with the nephrotic syndromeA report from the Southwest Pediatric Nephrology Study Group.

Lande MB, Gullion C, Hogg RJ, Gauthier B, Shah B, Leonard MB, Bonilla-Felix M, Nash M, Roy S 3rd, Strife CF, Arbus G.

Pediatr Nephrol. 2003 Apr;18(4):342-6. Epub 2003 Mar 21.

PMID:
12700959
26.

Varicella vaccination in children with chronic renal failure. A report of the Southwest Pediatric Nephrology Study Group.

Furth SL, Hogg RJ, Tarver J, Moulton LH, Chan C, Fivush BA; Southwest Pediatric Nephrology Study Group.

Pediatr Nephrol. 2003 Jan;18(1):33-8. Epub 2002 Nov 22.

PMID:
12488988
27.

Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure.

Watkins SL, Alexander SR, Brewer ED, Hesley TM, West DJ, Chan IS, Mendelman P, Bailey SM, Burns JL, Hogg RJ; Southwest Pediatric Nephrology Study Group.

Am J Kidney Dis. 2002 Aug;40(2):365-72.

PMID:
12148110
28.

Screening for eligibility in the study of antihypertensive medication in children: experience from the Ziac Pediatric Hypertension Study.

Sorof JM, Urbina EM, Cunningham RJ, Hogg RJ, Moxey-Mims M, Eissa MA, Rolf C; Ziac Pediatric Hypertension Study Group.

Am J Hypertens. 2001 Aug;14(8 Pt 1):783-7.

PMID:
11497194
29.

Evidence-based assessment of treatment options for children with IgA nephropathies.

Wyatt RJ, Hogg RJ.

Pediatr Nephrol. 2001 Feb;16(2):156-67. Review.

PMID:
11261686
30.

Avascular necrosis of the femoral head in children with chronic renal disease.

Boechat MI, Winters WD, Hogg RJ, Fine RN, Watkins SL.

Radiology. 2001 Feb;218(2):411-3.

PMID:
11161154
32.

Issues in the design and implementation of multicenter studies in pediatric nephrology.

Hogg RJ, Gray J.

Blood Press Monit. 1999 Jun-Aug;4(3-4):193-6. Review.

PMID:
10490875
33.
34.

Renal tract abnormalities detected in Australian preschool children.

Hogg RJ, Harris S, Lawrence DM, Henning PH, Wigg N, Jureidini KF.

J Paediatr Child Health. 1998 Oct;34(5):420-4.

PMID:
9767503
35.

Current concepts and controversies in IgA nephropathy.

Waldo FB, Wyatt RJ, Hogg RJ, Andreoli SP, Milliner DS.

Pediatr Nephrol. 1998 Aug;12(6):498-504. Review. No abstract available.

PMID:
9745877
36.

The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group.

Powell DR, Durham SK, Liu F, Baker BK, Lee PD, Watkins SL, Campbell PG, Brewer ED, Hintz RL, Hogg RJ.

J Clin Endocrinol Metab. 1998 May;83(5):1654-61.

PMID:
9589673
37.

Continuous veno-venous hemodiafiltration using bicarbonate dialysate.

Roy D, Hogg RJ, Wilby PA, Matthews N, Henning PH, Jureidini KF.

Pediatr Nephrol. 1997 Dec;11(6):680-3.

PMID:
9438641
38.

Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group.

Powell DR, Liu F, Baker BK, Hintz RL, Durham SK, Brewer ED, Frane JW, Tonshoff B, Mehls O, Wingen AM, Watkins SL, Hogg RJ, Lee PD.

J Clin Endocrinol Metab. 1997 Sep;82(9):2978-84.

PMID:
9284730
39.

Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group.

Powell DR, Liu F, Baker BK, Hintz RL, Lee PD, Durham SK, Brewer ED, Frane JW, Watkins SL, Hogg RJ.

Kidney Int. 1997 Jun;51(6):1970-9.

40.

Genetic factors as predictors for desmopressin treatment success.

Hogg RJ.

Scand J Urol Nephrol Suppl. 1997;183:37-9. Review.

PMID:
9165604
41.

Advances in treatment: immunoglobulin A nephropathy.

Hogg RJ, Waldo B.

Semin Nephrol. 1996 Nov;16(6):511-6. Review.

PMID:
9125795
43.

Prognostic indicators and treatment of childhood IgA nephropathy.

Hogg RJ.

Contrib Nephrol. 1995;111:194-9; discussion 199-200. No abstract available.

PMID:
7758342
44.

Deciding on decision analysis.

Hogg RJ.

Pediatr Nephrol. 1994 Dec;8(6):665-6. No abstract available.

PMID:
7696101
45.

Etiology of sustained hypertension in children in the southwestern United States.

Arar MY, Hogg RJ, Arant BS Jr, Seikaly MG.

Pediatr Nephrol. 1994 Apr;8(2):186-9.

PMID:
8018497
46.
47.

Prognostic indicators in children with IgA nephropathy--report of the Southwest Pediatric Nephrology Study Group.

Hogg RJ, Silva FG, Wyatt RJ, Reisch JS, Argyle JC, Savino DA.

Pediatr Nephrol. 1994 Feb;8(1):15-20.

PMID:
8142218
48.
49.

Serial measurements of GFR in infants using the continuous iothalamate infusion technique. Southwest Pediatric Nephrology Study Group (SPNSG).

Holliday MA, Heilbron D, al-Uzri A, Hidayat J, Uauy R, Conley S, Reisch J, Hogg RJ.

Kidney Int. 1993 Apr;43(4):893-8.

50.

Prognostication in children with renal disease--with emphasis on IgA nephropathy.

Hogg RJ, Browne R.

Pediatr Nephrol. 1993 Apr;7(2):130-1. No abstract available.

PMID:
8476702

Supplemental Content

Support Center